TP53

There are 2,514 papers on TP53 in aging research: 23 trials and 306 observational studies in people, 1,118 in animals, 749 in cells, 236 reviews. The newest story, Nov 19, 2026: “Hydrogen sulfide may ease signs of heart aging in mice”.

Gene

2,514 papers study it538 findings

HGNCMGINCBI GeneTaxon

71 new papers in 30 daysSee all 2,514 papers on TP53

At a glance

TP53 shortens lifespan in mice and increases senescence in human cells in experiments replicated by independent labs; other experiments show no clear lifespan effect in mice or lifespan extension in zebrafish. Some studies include company-affiliated authors, and some papers declare company ties.

538 findings in 406 papers from 1991 to 2026, 42 of them since April 2026

Independent labs found the same change in cells, mice and people. 216 independent labs in 34 countries.

“Classic LFS alleles at high VAF conferred markedly increased risk of hematological malignancy but not solid tumors”
Shared inheritance reveals landscape of somatic and germline cancer risk in TP53American journal of human genetics2026doi:10.1016/j.ajhg.2026.07.011

21 of its findings point the other way.

Cells, mice and humans: replicated by independent labs. Worms or flies: a single group.
  • 216 independent labs in 34 countries
  • 21 findings against
  • Funders: National Institutes of Health and others
  • 33 of 455 findings with company ties
  • Human trial23
  • Humans306
  • Animals1,099
  • Model organisms19
  • Cells749
  • In silico75

Interventions

45

Quercetin

downin human cells1upin human cells1

2 studies
  1. Quercetin decreases TP53 in IL-1β-induced chondrocytes.

    “decreased macrophage pro-inflammatory polarization, correlating with reduced p53 expression”

    Cellsin IL-1β-induced chondrocytes

    Integrative transcriptomics and single-cell analysis unravel the senescence-reversing mechanism of quercetin in osteoarthritic chondrocytes

    Biochemical and biophysical research communications

  2. Quercetin activates TP53 in endometrial stromal cells.

    “enhancing the phosphorylation of p53 and total p53 levels.”

    Cellsin endometrial stromal cellsendometrium25 μM

    Quercetin enhances decidualization through AKT-ERK-p53 signaling and supports a role for senescence in endometriosis

    Reproductive biology and endocrinology : RB&E

More on Quercetin

Fisetin

downin cells1downin rats1

2 studies
  1. Fisetin decreases TP53 in rats after partial hepatectomy, mRNA expression.

    “Fisetin reduced PHx-induced increases in p53, indicating suppression of cell senescence”

    Animalsafter partial hepatectomy, mRNA expressionliver10 mg/kg/day

    Fisetin promotes liver regeneration by inducing β-catenin-mediated inhibition of p53 and suppression of TGF-β

    Tissue & cell

  2. Fisetin decreases TP53 in cells (patulin-induced injury in H9c2 cardiomyocytes; protein expression).

    “FIS inhibits the protein overexpression of P53, Caspase-9 and Bax.”

    Cellspatulin-induced injury in H9c2 cardiomyocytes; protein expression

    Effect and mechanism of Fisetin on myocardial damage induced by Patulin

    Molecular biology reports

More on Fisetin

Resveratrol

downin cells1upin humans1

2 studies
  1. Resveratrol increases TP53 in humans (type 2 diabetes) (fold change 1.29, p = .04).

    “Resveratrol supplementation significantly increased mRNA expression levels of p53 and p21 genes, compared with the placebo group (fold change of p53 = 1.29, p = .04; fold change of p21 = 1.46, p = .006).”

    Human trialtype 2 diabetestrans-resveratrol1,000 mg8 weeksn = 71

    The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A double-blind controlled randomized trial

    Phytotherapy research : PTR

  2. Resveratrol decreases TP53 in cells.

    “And then it is attested that cells have a lower level of p53 but SIRT1 expression is upregulated on RSV-AA-P(CL-DLLA)”

    Cellsconjugated to P(CL-DLLA) scaffold surfacehepatic stellate cells

    Fabrication of Resveratrol-Loaded Scaffolds and Their Application for Delaying Cell Senescence In Vitro

    Macromolecular bioscience

More on Resveratrol

Rapamycin

downin human cells1downin mouse cells1

2 studies
  1. Rapamycin decreases TP53 in human cells (UVA-induced human dermal fibroblasts).

    “decreased the expression of p53 and phosphorylated HSP27, and reduced genotoxic and oxidative cellular stress levels in UVA-induced HDFs”

    CellsUVA-induced human dermal fibroblasts

    Rapamycin Protects Skin Fibroblasts From UVA-Induced Photoaging by Inhibition of p53 and Phosphorylated HSP27

    Frontiers in cell and developmental biology

  2. Rapamycin decreases TP53 in mouse cells.

    “rapamycin could upregulate ULK1, ATG13 and downregulate mTORC1 and p53 protein expression.”

    Cells

    Moderate Autophagy Inhibits Vascular Smooth Muscle Cell Senescence to Stabilize Progressed Atherosclerotic Plaque via the mTORC1/ULK1/ATG13 Signal Pathway

    Oxidative medicine and cellular longevity

More on Rapamycin

Hypoxia

downin cells1upin rats1

2 studies
  1. Hypoxia decreases TP53 in cells (irrespective of passage).

    “Irrespective of the passage, genes ANGPTL4, GYS1, PKM2, SERPINE1, and TP53 were downregulated under hypoxia.”

    Cellsirrespective of passage5% oxygen

    Alteration of Hypoxia-Associated Gene Expression in Replicatively Senescent Mesenchymal Stromal Cells under Physiological Oxygen Level

    Biochemistry. Biokhimiia

  2. Hypoxia increases TP53 in rats (hypoxia).

    “These events are paralleled by p53 and HIF-1 α expression dramatic increase and by p53/ HIF-1 α co-immunoprecipitation in the hypoxic young”

    Animalshypoxiaheart

    p53 and telomerase control rat myocardial tissue response to hypoxia and ageing

    European journal of histochemistry : EJH

More on Hypoxia

Caloric restriction

downin human cells1downin mice1

2 studies
  1. Caloric restriction decreases TP53 in mice (juvenile mice).

    “Both CR and RSV downregulated p53 and upregulated IGF-1 in hippocampal CA1 region of mice.”

    Animalsjuvenile micehippocampal CA1 region6 monthsn = 12

    Comparison of the effects of resveratrol and caloric restriction on learning and memory in juvenile C57BL/6J mice

    Iranian journal of basic medical sciences

  2. Caloric restriction decreases TP53 in human cells (serum from calorie-restricted animals, correlated with senescence effects).

    “These effects correlated with CR-mediated increases in SIRT1 and decreases in p53 expression levels.”

    Cellsserum from calorie-restricted animals, correlated with senescence effectsserum

    Serum from calorie-restricted animals delays senescence and extends the lifespan of normal human fibroblasts in vitro

    Aging

More on Caloric restriction

Formononetin

downin human cells1

1 study
  1. Formononetin decreases TP53 in senescent fibroblasts.

    “Formononetin-induced proliferation was associated with the suppression of expression of key cell cycle inhibitors, including p53 and Rb-1.”

    Cellsin senescent fibroblasts

    Formononetin attenuates cellular senescence through a FOS-mediated mechanism

    Biogerontology

More on Formononetin

Carica papaya

downin humans1

1 study
  1. Carica papaya decreases TP53 in humans following a Mediterranean diet.

    “induced a protective downregulation of p53 expression, particularly within the cytoplasmic compartment.”

    Human trialfollowing a Mediterranean dietperipheral blood mononuclear cells3 months

    Effects of redox modulation on postprandial oxy-inflammatory transcriptomic responses in overweight adults with cardiometabolic risk following a Mediterranean diet

    Eurasian Journal of Medicine and Oncology

More on Carica papaya

Metformin

upin mice1

1 study
  1. Metformin increases TP53 in mice (cytoplasmic expression).

    “Met dramatically increased the cytoplasmic expression of p53 and Parkin”

    Animalscytoplasmic expressionhippocampus

    Metformin Ameliorates Diabetes-Associated Cognitive Dysfunction via p53/Parkin-Mediated Mitophagy

    Diabetes, obesity & metabolism

More on Metformin

Acetylglutamine

downin human cells1

1 study
  1. Acetylglutamine decreases TP53 in cyclophosphamide-injured KGN cells.

    “attenuating p21 and p53 upregulation”

    Cellsin cyclophosphamide-injured KGN cells

    Integrative serum metabolite prioritization and functional screening identify N-acetyl-L-glutamine as a protective candidate in premature ovarian insufficiency

    Frontiers in genetics

More on Acetylglutamine

All 45

Effects

220

Cellular senescence

is required forin human cells10upin reviews7upin mouse cells5upin human cells4+16

55 studies
  1. TP53 induces cellular senescence (sustained activation in healthy cells).

    “sustained activation of p53 stress-response in healthy cells may accelerate cellular senescence”

    Reviewsustained activation in healthy cells

    Context-Dependent Roles of p53 in Cellular Senescence and Fibrosis

    Aging and disease

  2. TP53 activates cellular senescence in matrix-producing myofibroblasts.

    “activation of the cellular senescence pathway in matrix-producing myofibroblasts”

    Reviewin matrix-producing myofibroblasts

    Context-Dependent Roles of p53 in Cellular Senescence and Fibrosis

    Aging and disease

  3. TP53 is required for cellular senescence in human cells (maintenance of stable senescence in CTCs through a p53-mtROS positive feedback loop).

    “a positive feedback loop between p53 and mtROS was essential for maintaining stable senescence in CTCs.”

    Cellsmaintenance of stable senescence in CTCs through a p53-mtROS positive feedback loop

    Cortactin Suppresses mTOR-Dependent Senescence in Circulating Tumor Cells

    Cancer research

  4. TP53 is required for cellular senescence in mouse cells (mechanically-induced).

    “Mechanically-induced CF senescence depends on p53/p21”

    Cellsmechanically-inducedheart

    Mechanical Stress Triggers Premature Senescence in Cardiac Fibroblasts

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  5. TP53 mediates cellular senescence.

    “p53 is critically involved in the regulation of senescence and fibrosis-related diseases”

    Review

    The Role of p53-Mediated Cellular Senescence in Idiopathic Pulmonary Fibrosis

    Comprehensive physiology

  6. TP53 increases cellular senescence in mouse cells.

    “p53 not only promotes cellular senescence in vitro and in vivo but also reciprocally enhances TET3 and 5-hmC levels.”

    Cellsendothelial cell

    Tet Methylcytosine Dioxygenase 3 Promotes Cardiovascular Senescence by DNA 5-Hydroxymethylcytosine-Mediated Sp1 Transcription Factor Expression

    MedComm

  7. TP53 increases cellular senescence in MLE-12 cells exposed to 1-NP.

    “P53 knockdown mitigated 1-NP-induced cell cycle arrest and senescence in MLE-12 cells.”

    Cellsin MLE-12 cells exposed to 1-NP

    Histone lactylation-induced premature senescence contributes to 1-nitropyrene-Induced chronic obstructive pulmonary disease

    Redox biology

  8. TP53 is required for cellular senescence in ATM-deficient fibroblasts, shown by knockout.

    “the concomitant loss of ATM and p53 led to senescence evasion”

    Cellsin ATM-deficient fibroblasts, shown by knockoutlung fibroblast

    The cGAS-STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts

    Proceedings of the National Academy of Sciences of the United States of America

  9. TP53 induces cellular senescence in animals (TP53 activation in spinal cord injury models).

    “TP53 activation induces cellular senescence in aging neurons”

    AnimalsTP53 activation in spinal cord injury modelsneuron

    p53/HIF-1α regulates neuronal aging and autophagy in spinal cord ischemia/reperfusion injury

    Mechanisms of ageing and development

  10. TP53 increases cellular senescence in endothelial cells.

    “Overall, our results demonstrate that p53 can accelerate the senescence process of endothelial cells and aggravate the development of DR.”

    Cellsin endothelial cellsretinal endothelial cells

    p53 accelerates endothelial cell senescence in diabetic retinopathy by enhancing FoxO3a ubiquitylation and degradation via UBE2L6

    Experimental gerontology

All 56

More on Cellular senescence

Lifespan

downin mice15upin mice4is required forin human cells1no changein mice1+1−20% median life span

22 studies
  1. TP53 extends lifespan in mice (Transgenic expression in a mouse model of Hutchinson-Gilford progeria syndrome).

    “Δ133p53α also mitigated spinal kyphosis and led to a modest increase in median lifespan.”

    AnimalsTransgenic expression in a mouse model of Hutchinson-Gilford progeria syndromeΔ133p53α isoform

    Human protein variant eased signs of progeria in mice

    NPJ aging

  2. TP53 extends lifespan in mice (shown by p53-null mice) (wild-type ~2–2.5 years versus p53-null ~3 months).

    “p53‐null mice die within ~3 months [1–8], traditionally attributed to spontaneous lymphomas; however, wild‐type mice live ~2–2.5 years”

    Reviewshown by p53-null mice

    Tumor Suppressors Are Longevity Genes: A Conceptual Shift in Cancer Biology

    Research SquarePreprint

  3. TP53 shortens lifespan in mice (mutant cells in male mice, over 18 months).

    “Over 18 months, male mice with Trp53 mutant cells showed worse survival than controls, which was exacerbated following radiation exposure.”

    Animalsmutant cells in male mice, over 18 months18 monthsmales

    Space radiation promotes clonal hematopoiesis and hematologic disease upon aging in a driver gene and sex-specific manner

    iScience

  4. TP53 extends lifespan in mice (Transgenic expression of human Δ133p53α in a heterozygous HGPS mouse model) (+11% median lifespan; 387 versus 349 days).

    “extends median lifespan by 11% (387 versus 349 days, P = 0.0379).”

    AnimalsTransgenic expression of human Δ133p53α in a heterozygous HGPS mouse model

    Senescence-inhibitory Δ133p53α counteracts accelerated ageing and mortality

    bioRxiv : the preprint server for biologyPreprint

  5. TP53 extends lifespan in mice (extra Trp53 copy, constitutive or inducible; Eu-myc lymphoma and LFS models).

    “mice live longer without observable side effects in both the Eu-myc lymphoma and LFS models”

    Animalsextra Trp53 copy, constitutive or inducible; Eu-myc lymphoma and LFS modelsthird copy of Trp53

    p53 prophylactic therapy for cancer prevention

    Cell death and differentiation

  6. TP53 shortens lifespan in mutant p53 mice overexpressing p53.

    “mutant p53 mice have shorter mean lifespans”

    Reviewin mutant p53 mice overexpressing p53

    Cancer Cachexia and Dysregulated Phosphate Metabolism: Insights from Mutant p53 and Mutant Klotho Mouse Models

    Metabolites

  7. TP53 shortens lifespan in mice (deficient for p53 core DNA-binding domain phosphorylation).

    “they had shortened lifespan, but did not show progeria-like phenotypes”

    Reviewdeficient for p53 core DNA-binding domain phosphorylation

    Balancing and Differentiating p53 Activities toward Longevity and No Cancer?

    Cancer research

  8. TP53 shortens lifespan in mice (p53 S180A knock-in) (-20%; 709 to 568 days median lifespan).

    “Median lifespan was significantly reduced by 20% from 709 days in wild type to only 568 days in S180A littermates.”

    Animalsp53 S180A knock-in

    Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging

    Cancer research

  9. TP53 shortens lifespan in Atg7-deficient mice.

    “Compared with Atg7Δ/Δ mice, the life span of Atg7Δ/Δp53Δ/Δ mice was extended due to delayed neurodegeneration and resistance to death upon fasting.”

    Animalsin Atg7-deficient mice

    Autophagy promotes mammalian survival by suppressing oxidative stress and p53

    Genes & development

  10. TP53 shortens lifespan in ERCC1-deficient mice, shown by knockout.

    “The healthspan and mean lifespan of ERCC1 deficient mice was rescued by inactivation of p53.”

    Animalsin ERCC1-deficient mice, shown by knockout

    Dysregulation of DAF-16/FOXO3A-mediated stress responses accelerates oxidative DNA damage induced aging

    Redox biology

All 22

Apoptosis

upin reviews3upin human cells2upin Chiroptera cells1no changein human cells1+3

10 studies
  1. TP53 increases apoptosis in osteoarthritis, via the miR-34a-SIRT1-p53 pathway.

    “Promoting chondrocyte apoptosis (via the miR-34a-SIRT1-p53 pathway in osteoarthritis)”

    Reviewin osteoarthritis, via the miR-34a-SIRT1-p53 pathwaychondrocyte

    The Multifaceted Role of p53 in Musculoskeletal Diseases: A Comprehensive Review

    International journal of rheumatic diseases

  2. TP53 increases apoptosis in Chiroptera cells (p53-dependent apoptosis in primary bat fibroblasts).

    “Bat fibroblasts exhibit increased TP53 and MDM2 transcripts and elevated p53-dependent apoptosis.”

    Cellsp53-dependent apoptosis in primary bat fibroblastsfibroblast

    Limited cell-autonomous anticancer mechanisms in long-lived bats

    Nature communications

  3. TP53 mediates apoptosis in mice (initiation shown with Puma/Bbc3 tdTomato reporter mice in a p53-deficient background).

    “the new reporters reliably inform on p53-dependent and p53-independent initiation of both apoptotic or cell cycle arrest/senescence programs, respectively, in vitro and in vivo”

    Animalsinitiation shown with Puma/Bbc3 tdTomato reporter mice in a p53-deficient background

    Mouse models to investigate in situ cell fate decisions induced by p53

    The EMBO journal

  4. TP53 induces apoptosis.

    “These programmes are mainly triggered and controlled by the tumour suppressor protein p53 and its complex network of effectors”

    Review

    At the Crossroads of Life and Death: The Proteins That Influence Cell Fate Decisions

    Cancers

  5. TP53 increases apoptosis in late-generation TERC KO mice; shown by knockout.

    “additional deficiency of the tumour suppressor p53 in the Trp53-/- allele of the late generation of TERC KO mice attenuates the increased senescent and apoptotic markers significantly”

    Animalsin late-generation TERC KO mice; shown by knockoutalveolar type 2 cells

    Pulmonary Alveolar Stem Cell Senescence, Apoptosis, and Differentiation by p53-Dependent and -Independent Mechanisms in Telomerase-Deficient Mice

    Cells

  6. TP53 induces apoptosis.

    “p53 also plays a role in apoptosis and negative regulation of SASP.”

    Review

    p53 regulated senescence mechanism and role of its modulators in age-related disorders

    Biochemical pharmacology

  7. TP53 increases apoptosis in human cells (gain of p53 function in lung myofibroblasts).

    “Gain of p53 function activates a gene program that sensitizes lung myofibroblasts to apoptosis”

    Cellsgain of p53 function in lung myofibroblastslung

    Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice

    The Journal of experimental medicine

  8. TP53 is required for apoptosis in zebrafish (young telomerase-deficient zebrafish upon telomere shortening).

    “In young telomerase mutants, proliferative tissues exhibit DNA damage and p53-dependent apoptosis, but no senescence.”

    Animalsyoung telomerase-deficient zebrafish upon telomere shorteningproliferative tissues

    Opposing p53 and mTOR/AKT promote an in vivo switch from apoptosis to senescence upon telomere shortening in zebrafish

    eLife

  9. TP53 showed no clear effect on apoptosis in human cells (MYC-induced apoptosis; shown by knockdown).

    “depletion of p53, which enhanced proliferation and rescued the cells from RAS-induced senescence, did not abrogate MYC-induced apoptosis”

    CellsMYC-induced apoptosis; shown by knockdown

    MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts

    Cell cycle (Georgetown, Tex.)

  10. TP53 induces apoptosis in human cells.

    “After 12 h of DEP exposure, HUVEC reduced Mdm2 expression leading to increased p53 expression, which triggered apoptosis”

    Cellshuman umbilical vein endothelial cells12 h

    Diesel Exhaust Particles Contribute to Endothelia Apoptosis via Autophagy Pathway

    Toxicological sciences : an official journal of the Society of Toxicology

More on Apoptosis

Mitophagy

downin cells1upin mice1downin mice1is required forin mouse cells1

4 studies
  1. TP53 is required for mitophagy in mouse cells (metformin-induced reduction of mitophagy, blocked by PFT-α).

    “the effect of Met on mitophagy and p53 was blocked by the p53 inhibitor PFT-α.”

    Cellsmetformin-induced reduction of mitophagy, blocked by PFT-α

    Metformin Ameliorates Diabetes-Associated Cognitive Dysfunction via p53/Parkin-Mediated Mitophagy

    Diabetes, obesity & metabolism

  2. TP53 activates mitophagy in mice (shown by ablation in differentiated adipocytes during cold-induced beiging).

    “p53-ablation reduced microtubule-associated protein light chain 3-mediated mitochondria clearance (mitophagy)”

    Animalsshown by ablation in differentiated adipocytes during cold-induced beigingwhite adipose tissue

    Transient p53 inhibition sensitizes aged white adipose tissue for beige adipocyte recruitment by blocking mitophagy

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

  3. TP53 inhibits mitophagy in cells (via disturbed mitochondrial translocation of Parkin).

    “Cytosolic p53 inhibited mitophagy by disturbing the mitochondrial translocation of Parkin, as demonstrated by immunoprecipitation.”

    Cellsvia disturbed mitochondrial translocation of Parkin

    Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53

    International journal of molecular sciences

  4. TP53 inhibits mitophagy in mice (cytosolic p53).

    “cytosolic p53 impairs autophagic degradation of damaged mitochondria”

    Animalscytosolic p53

    Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart

    Nature communications

More on Mitophagy

Cell proliferation

downin mice1downin mouse cells1downin zebrafish1

3 studies
  1. TP53 inhibits cell proliferation in cells with low UHRF1 levels, shown by tp53 mutants.

    “Cells with low UHRF1 levels proliferate in tp53 mutants”

    Animalsin cells with low UHRF1 levels, shown by tp53 mutantsliver

    UHRF1 levels drive distinct senescent states in zebrafish liver cells

    EMBO reports

  2. TP53 inhibits cell proliferation in mouse cells (cells lacking functional SLC25A1; shown by p53 RNA interference).

    “removal of p53 activity via RNA interference restores proliferation”

    Cellscells lacking functional SLC25A1; shown by p53 RNA interference

    Inactivation of the SLC25A1 gene during embryogenesis induces a unique senescence program controlled by p53

    Cell death and differentiation

  3. TP53 impairs cell proliferation in mice (SLC25A1 dysfunction).

    “blocking p53 activity reverses the growth defect caused by SLC25A1 dysfunction and restores proliferation”

    AnimalsSLC25A1 dysfunction

    Loss of the mitochondrial carrier, SLC25A1, during embryogenesis induces a unique senescence program controlled by p53

    bioRxiv : the preprint server for biologyPreprint

PPARGC1A

upin human cells1downin mice1upin mouse cells1

3 studies
  1. TP53 increases PPARGC1A in late-stage p53S/+ mouse embryonic fibroblasts expressing HRasV12.

    “We found that p53S increased the level and nuclear translocation of PGC-1α in late-stage p53S/++Ras cells”

    Cellsin late-stage p53S/+ mouse embryonic fibroblasts expressing HRasV12

    Gain-of-Function p53N236S Mutation Drives the Bypassing of HRasV12-Induced Cellular Senescence via PGC-1α

    International journal of molecular sciences

  2. TP53 activates PPARGC1A in human cells (upon GSH shortage (chemical depletion or fasting)).

    “p53 binds to the PPARGC1A promoter of both human and mouse genes, and this event is positively related to increased PGC-1α expression.”

    Cellsupon GSH shortage (chemical depletion or fasting)

    p53 orchestrates the PGC-1α-mediated antioxidant response upon mild redox and metabolic imbalance

    Antioxidants & redox signaling

  3. TP53 decreases PPARGC1A in the setting of telomere dysfunction.

    “telomere dysfunction activates p53 which in turn binds and represses PGC-1α and PGC-1β promoters”

    Animalsin the setting of telomere dysfunction

    Telomere dysfunction induces metabolic and mitochondrial compromise

    Nature

More on PPARGC1A

Senescence-associated secretory phenotype (SASP)

downin human cells1downin reviews1mediatesin reviews1

3 studies
  1. TP53 inhibits senescence-associated secretory phenotype (SASP).

    “p53 also plays a role in apoptosis and negative regulation of SASP.”

    Review

    p53 regulated senescence mechanism and role of its modulators in age-related disorders

    Biochemical pharmacology

  2. TP53 mediates senescence-associated secretory phenotype (SASP) (non-cell-autonomous responses to DNA damage).

    “by mediating the SASP function of immune system activation”

    Reviewnon-cell-autonomous responses to DNA damage

    p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions

    International journal of molecular sciences

  3. TP53 inhibits senescence-associated secretory phenotype (SASP) in human cells (Restored Δ133p53 expression in near-senescent astrocytes).

    “Restored expression of Δ133p53 in near-senescent, otherwise neurotoxic astrocytes conferred them with neuroprotective activity through repression of SASP and induction of neurotrophic growth factors.”

    CellsRestored Δ133p53 expression in near-senescent astrocytesastrocyte

    p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration

    Cell death and differentiation

More on Senescence-associated secretory phenotype (SASP)

Mitochondrial elongation

upin cells1is required forin human cells1upin human cells1

2 studies
  1. TP53 is required for mitochondrial elongation in human cells (H-Ras-induced cellular senescence and replicative senescence).

    “p53 plays an essential role in mitochondrial elongation in H-Ras-induced cellular senescence and in the replicative senescence of normal human cells”

    CellsH-Ras-induced cellular senescence and replicative senescence

    p53-mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

  2. TP53 increases mitochondrial elongation in human cells.

    “p53 induced remarkable mitochondrial elongation and cellular senescence in various cancer cells regardless of their p53 status”

    Cellscancer cell lines

    p53-mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

  3. TP53 increases mitochondrial elongation in cells (p53 expression).

    “We found that p53 promoted the formation of highly interconnected and elongated mitochondria prior to the onset of cellular senescence.”

    Cellsp53 expression

    p53 regulates mitochondrial dynamics by inhibiting Drp1 translocation into mitochondria during cellular senescence

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

CDKN1A expression

is required forin cells1downin mice1

2 studies
  1. TP53 decreases CDKN1A expression in mice (Transgenic expression in a mouse model of Hutchinson-Gilford progeria syndrome).

    “transgenic expression of Δ133p53α, a senescence-inhibitory human p53 isoform, reduced the expression of p21 Waf1/Cip1”

    AnimalsTransgenic expression in a mouse model of Hutchinson-Gilford progeria syndromeΔ133p53α isoformmultiple tissues

    Human protein variant eased signs of progeria in mice

    NPJ aging

  2. TP53 is required for CDKN1A expression in cells (Required for EYA4-SIX2-mediated regulation; shown by absence of p53).

    “the EYA4-SIX2-mediated regulation of p21 expression is p53-dependent, as the absence of p53 abolished this regulatory effect.”

    CellsRequired for EYA4-SIX2-mediated regulation; shown by absence of p53

    EYA4 promotes cellular senescence by enhancing P21 transcription through interaction with SIX2

    Advanced biotechnology

More on CDKN1A expression

Tubulointerstitial fibrosis

mediatesin cells1mediatesin humans1

2 studies
  1. TP53 mediates tubulointerstitial fibrosis in cells (Nutlin-3a reversed the protection conferred by CYFIP2 knockout).

    “The p53 agonist Nutlin-3a reversed the protective effect of CYFIP2 knockout”

    CellsNutlin-3a reversed the protection conferred by CYFIP2 knockout

    CYFIP2 deficiency ameliorates renal interstitial fibrosis through attenuating tubular senescence in hypertensive nephropathy

    Acta pharmacologica Sinica

  2. TP53 mediates tubulointerstitial fibrosis in humans (convergence of secondary CKD genetic risk factors on p53 hyperactivation).

    “it is this convergence on p53 hyperactivation - not the upstream diversity - that determines the shared fibrotic endpoint”

    Reviewconvergence of secondary CKD genetic risk factors on p53 hyperactivationkidney

    p53 as a Convergent Genetic Modifier in Chronic Kidney Disease: Unifying the Secondary Risk Gene Landscape and Defining the Conceptual Basis for Renal Modulatory Drugs (RMDs)

    Zenodo (CERN European Organization for Nuclear Research)Preprint

More on Tubulointerstitial fibrosis

All 220

Upstream

47

ATM

upin human cells1upin reviews1

2 studies
  1. ATM activates TP53 (Ser15 phosphorylation of p53).

    “ATM → p53(Ser15) → centrosome localization → postmitotic checkpoint arrest is causally established”

    ReviewSer15 phosphorylation of p53

    A Stochastic Model of Centriole-Driven Stem Cell Exhaustion

    Longevity Horizon

  2. ATM activates TP53 in a subset of senescent cells with telomeric foci.

    “signaled through ATM to p53, upregulating p21 and causing G1 phase arrest”

    Cellsin a subset of senescent cells with telomeric foci

    Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a)

    Molecular cell

More on ATM

SIRT1

downin mice1downin reviews1

2 studies
  1. SIRT1 decreases TP53 in mice (deacetylation following irisin-restored SIRT1).

    “Further exploration revealed that irisin treatment restored sirtuin 1 (SIRT1) levels, leading to deacetylation of P53 and subsequent reduction in its expression.”

    Animalsdeacetylation following irisin-restored SIRT1recombinant

    Irisin ameliorates age-associated skeletal muscle atrophy in mice: potential involvement of iron overload and SIRT1/p53 pathway

    Journal of physiology and biochemistry

  2. SIRT1 inhibits TP53.

    “It also modulates cell cycle through p53 inactivation”

    Reviewvascular wall

    SIRT-associated attenuation of cellular senescence in vascular wall

    Mechanisms of ageing and development

More on SIRT1

MTOR

upin human cells1upin mouse cells1

2 studies
  1. MTOR activates TP53 in human cells within enlarged late endosomal aggregates after cortactin depletion.

    “The mTOR protein complex was accumulated and activated within these abnormal vesicular structures, leading to robust p53 activation”

    Cellswithin enlarged late endosomal aggregates after cortactin depletion

    Cortactin regulates metastatic dormancy of circulating tumor cells by suppressing mTOR-dependent senescence

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  2. MTOR activates TP53 in mouse cells (phosphorylation at serine 15).

    “mTOR kinase, a major component of mTORC1 and mTORC2, directly binds p53 and phosphorylates it at serine 15.”

    Cellsphosphorylation at serine 15

    mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53

    Oncogene

More on MTOR

AMPK signaling

upin human cells1upin silico1

2 studies
  1. AMPK signaling activates TP53 in silico.

    “AMPK is first activated upon glucose limitation, activating p53 to induce cell-cycle arrest”

    In silico

    Coordination of the AMPK, Akt, mTOR, and p53 Pathways under Glucose Starvation

    International journal of molecular sciences

  2. AMPK signaling activates TP53 in human cells (mediates suppression of the IL-1-associated SASP).

    “prevented the IL-1-associated SASP through AMPK-mediated p53 activation”

    Cellsmediates suppression of the IL-1-associated SASP

    Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype

    Cell metabolism

More on AMPK signaling

miR-21-5p

downin silico1

1 study
  1. miR-21-5p decreases TP53 in silico (shown by computational modeling and multi-omics analysis).

    “elevated miR-21-5p directly targets and silences key tumor suppressors and metabolic controllers, including TP53 and PTEN”

    In silicoshown by computational modeling and multi-omics analysis

    Small RNA linked to death in younger people with COVID-19

    Research SquarePreprint

More on miR-21-5p

CERS6

upin cells1

1 study
  1. CERS6 activates TP53 in cells (stress-induced senescence).

    “CerS6 acts upstream of p53 to drive stress-induced senescence”

    Cellsstress-induced senescence

    Podocyte-specific CerS6 Drives Renal Aging via C16 Ceramide-mediated p53-p21 Senescence

    Research SquarePreprint

More on CERS6

AURKA

downin reviews1

1 study
  1. AURKA inhibits TP53 (via Ser315-Mdm2 degradation and Ser215 abrogation of DNA-binding).

    “Aurora A inactivates p53 through two independent mechanisms”

    Reviewvia Ser315-Mdm2 degradation and Ser215 abrogation of DNA-binding

    A Stochastic Model of Centriole-Driven Stem Cell Exhaustion

    Longevity Horizon

More on AURKA

MIF

downin human cells1

1 study
  1. MIF inhibits TP53 in human cells (shown by disruption of MIF signaling).

    “human macrophages rely on autocrine macrophage migration inhibitory factor signaling to suppress p53 during M2-like transition”

    Cellsshown by disruption of MIF signaling

    Blocking a signal gives human immune cells tumor-linked traits

    Molecular biomedicine

More on MIF

MIR196A1

downin human cells1

1 study
  1. MIR196A1 decreases TP53 in human corneal endothelial cells.

    “activated prosurvival pathways (YAP, MAPK) and reduced p53 levels.”

    Cellsin human corneal endothelial cells

    Therapeutic Potential of miR-196a in Protecting Corneal Endothelial Cells From Senescence Through Mitochondrial and TGF-β Signaling Modulation

    Translational vision science & technology

More on MIR196A1

ENO2

upin human cells1

1 study
  1. ENO2 increases TP53 in vitro chondrocytes.

    “ENO2 bound GNL3 lactylated at Lys-5. This interaction displaced MDM2 from GNL3, resulting in MDM2 destabilization, impaired ubiquitination, p53 accumulation”

    Cellsin vitro chondrocytes

    Enolase 2-mediated lactylation-dependent disruption of the GNL3-MDM2-p53 axis in age-related osteoarthritis

    Cellular & molecular biology letters

More on ENO2

All 47

Associations

93

Lifespan

upin silico2upin flies1mixedin silico1mixedin mice1+1

6 studies
  1. TP53 is associated with lifespan in silico.

    “RES algorithm found variations in the alignments within and across orders, suggesting that mechanisms of p53-mediated regulation of longevity may vary”

    In silico

    Structural and mechanistic diversity in p53-mediated regulation of organismal longevity across taxonomical orders

    bioRxiv : the preprint server for biologyPreprint

  2. TP53 is associated with lifespan in silico.

    “We discovered new correlations between specific amino acid deviations in p53 and the lifespans across different animal species.”

    In silico

    The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity

    International journal of molecular sciences

  3. TP53 is associated with lifespan in species with extended lifespan, via amino acid substitutions in the DNA-binding domain.

    “We found that species with extended lifespan have certain characteristic amino acid substitutions in the p53 DNA binding domain”

    In silicoin species with extended lifespan, via amino acid substitutions in the DNA-binding domain

    The changes in the p53 protein across the animal kingdom pointing to its involvement in longevity

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  4. TP53 is associated with lifespan in rats (untreated male Tp53 homozygous knockout rats, Wistar background) (median 133 days).

    “The average lifespan of untreated male Tp53 homozygous knockout rats was normally distributed, with a median of 133 days.”

    Animalsuntreated male Tp53 homozygous knockout rats, Wistar backgroundmales

    Survival rates of homozygotic Tp53 knockout rats as a tool for preclinical assessment of cancer prevention and treatment

    Cellular & molecular biology letters

  5. TP53 is associated with lifespan in flies (Shown by p53 mutation; mortality parameter changes differed in direction between sexes).

    “p53 mutation in Drosophila and mTOR mutation in mice caused increased median life span”

    Model organismsShown by p53 mutation; mortality parameter changes differed in direction between sexes

    Multiple Metazoan Life-span Interventions Exhibit a Sex-specific Strehler-Mildvan Inverse Relationship Between Initial Mortality Rate and Age-dependent Mortality Rate Acceleration

    The journals of gerontology. Series A, Biological sciences and medical sciences

  6. TP53 is associated with lifespan in mice (increased p53 activities).

    “increased p53 activities have been linked to both accelerated aging and increased life span in mice”

    Reviewincreased p53 activities

    p53, oxidative stress, and aging

    Antioxidants & redox signaling

Cellular senescence

downin human cells1upin humans1upin silico1upin mouse cells1+1

5 studies
  1. TP53 is associated with cellular senescence in humans.

    “with increased P53 expression associated with senescence in these cells”

    Humanstumor tissue

    Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis

    Neuro-oncology

  2. TP53 is associated with cellular senescence in Col1a1+/G349C and Col1a2+/G610C osteoblasts.

    “Transcriptomic analysis identified P53 as a central hub gene, supporting premature senescence activation.”

    Cellsin Col1a1+/G349C and Col1a2+/G610C osteoblastsosteoblasts

    OMICS Profiling Identifies Signatures of Senescence in Osteogenesis Imperfecta Osteoblasts Counteracted by 4-PBA

    Journal of cellular and molecular medicine

  3. TP53 is associated with cellular senescence in silico (simulations mapping p53 dynamics).

    “p 53 dynamics to fate: sustained moderate oscillations align with arrest, damped intermediate responses with senescence, and strongly damped high plateaus with apoptosis.”

    In silicosimulations mapping p53 dynamics

    STAT1–p53 Dynamics Program Cell Fate through p21 and PUMA

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  4. TP53 is associated with cellular senescence.

    “There is growing evidence that p53/MDM2 (murine double minute 2) axis is critically involved in regulation of aging, senescence and oncogenesis.”

    Review

    p53/MDM2 signaling pathway in aging, senescence and tumorigenesis

    Seminars in cancer biology

  5. TP53 is associated with cellular senescence in human cells.

    “Wild type p53-GFP exclusively localized in the nuclei of growing young fibroblast, in contrast to the significant cytoplasmic retention in senescent human fibroblasts.”

    Cellsfibroblast

    Cytoskeleton-Anchoring of Conformational Mutant-Like p53, but Not Shorter Isoforms p53β and p47 (ΔN40p53) in Senescent Human Fibroblasts

    Current aging science

More on Cellular senescence

Cancer

upin humans1upin mice1upin zebrafish1

3 studies
  1. TP53 is associated with cancer in humans (recurrent clonal hematopoiesis modulating the TP53 pathway).

    “a distinct group of recurrent CH that modulates TP53 pathway has been associated with cancer development in TBDs”

    Reviewrecurrent clonal hematopoiesis modulating the TP53 pathway

    Clonal Signatures of Telomere Biology Disorders

    Current hematologic malignancy reports

  2. TP53 raises the risk of cancer in tert-/- background.

    “tp53mut tert -/- zebrafish retain high levels of inflammation and increased spontaneous cancer incidence.”

    Animalsin tert-/- background

    Lack of telomerase reduces cancer incidence and increases lifespan of zebrafish tp53M214K mutants

    Scientific reports

  3. TP53 raises the risk of cancer in mice (loss of p53 function (inactivation)).

    “loss of p53 function enhances tumor susceptibility and reduces longevity in the mouse.”

    Reviewloss of p53 function (inactivation)

    Insights into aging obtained from p53 mutant mouse models

    Annals of the New York Academy of Sciences

More on Cancer

Hematologic malignancy

upin humans2

2 studies
  1. TP53 is linked with a higher risk of hematologic malignancy in humans (somatic mutation, regardless of clonal burden).

    “Chr1q+ and splicing factor or TP53 mutations significantly increased the risk of hematologic malignancies, regardless of clonal burden.”

    Humanssomatic mutation, regardless of clonal burden

    Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations

    Blood

  2. TP53 raises the risk of hematologic malignancy in humans (clonal hematopoiesis).

    “certain features of CH may confer a higher risk of transformation, including the presence of TP53 or spliceosome gene mutations”

    Reviewclonal hematopoiesis

    Clonal hematopoiesis and risk for hematologic malignancy

    Blood

More on Hematologic malignancy

DNA methylation age acceleration

downin humans2

2 studies
  1. TP53 is associated with DNA methylation age acceleration in humans (somatic mutation).

    “variables indicating extensive genomic instability, such as TP53 somatic mutations, high tumor mutation/copy number alteration burden, and homologous repair deficiency were associated with lower DNAm AA.”

    Humanssomatic mutationbreast tumorfemales

    DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer

    Clinical epigenetics

  2. TP53 is associated with DNA methylation age acceleration in humans (cancer tissue).

    “Low age-acceleration of cancer tissue is associated with a high number of somatic mutations and TP53 mutations”

    Humanscancer tissuen = 6,000

    DNA methylation age of human tissues and cell types

    Genome biology

More on DNA methylation age acceleration

Poor prognosis

upin humans2

2 studies
  1. TP53 is linked with a higher risk of poor prognosis in humans (combined with ATRX mutation).

    “Patients with the double mutation showed poorer prognosis than those with the double wild type genotype.”

    Humanscombined with ATRX mutation

    Transcriptomic Landscape of Lower Grade Glioma Based on Age-Related Non-Silent Somatic Mutations

    Current oncology (Toronto, Ont.)

  2. TP53 predicts poor prognosis in humans among elderly AML patients.

    “DNMT3A and TP53 mutations were independent poor prognostic factors among the elderly”

    Humansamong elderly AML patients

    Genetic alterations and their clinical implications in older patients with acute myeloid leukemia

    Leukemia

Ageing gene network hub

no changein silico1

1 study
  1. TP53 is associated with ageing gene network hub in silico (hub gene in STRING network of mouse ageing genes).

    “TP53, Trp53 and Actb were identified as important genes in the network, contributing significantly to the process of ageing in humans, mice and rats, respectively”

    In silicohub gene in STRING network of mouse ageing genes

    Identification of Ageing-related Hub Genes in Humans, Mouse and Rat Based on Bioinformatics Analysis

    Annals of neurosciences

  2. TP53 is associated with ageing gene network hub in silico (hub gene in STRING network of human ageing genes).

    “TP53, Trp53 and Actb were identified as important genes in the network, contributing significantly to the process of ageing in humans, mice and rats, respectively”

    In silicohub gene in STRING network of human ageing genes

    Identification of Ageing-related Hub Genes in Humans, Mouse and Rat Based on Bioinformatics Analysis

    Annals of neurosciences

Progression to myelodysplastic syndrome or acute myeloid leukemia

upin humans1

1 study
  1. TP53 predicts progression to myelodysplastic syndrome or acute myeloid leukemia in humans (Shwachman-Diamond syndrome; dominant TP53 clone variant allele frequency above 0.074) (Dominant TP53 clone VAF >0.074 discriminated progressors from nonprogressors).

    “a variant allele frequency (VAF) of dominant TP53 clone above 0.074 discriminated between patients who progressed and those who did not.”

    HumansShwachman-Diamond syndrome; dominant TP53 clone variant allele frequency above 0.074

    Mutation patterns linked to blood cancer in inherited disorders

    bioRxivPreprint

More on Progression to myelodysplastic syndrome or acute myeloid leukemia

Muscle mass

downin humans1

1 study
  1. TP53 is associated with muscle mass in humans (genetically predicted expression using blood cis-eQTL).

    “Higher genetically predicted TP53 expression was associated with lower muscle mass.”

    Humansgenetically predicted expression using blood cis-eQTLwhole blood

    Blood cis-eQTL Mendelian Randomisation and Colocalisation among Candidate Targets of a Huangqi Eight-Herb Formula: TP53 Is the Only Supported Candidate

    In silico research in biomedicine

Selection for somatic copy-number alterations

upin humans1

1 study
  1. TP53 is associated with selection for somatic copy-number alterations in humans (TP53-mutant samples during later esophageal squamous-cell carcinoma progression).

    “copy-number alterations associated with later ESCC progression were more strongly selected in TP53 -mutant samples”

    HumansTP53-mutant samples during later esophageal squamous-cell carcinoma progressionesophagus

    Common mutations less favored as esophageal cancer develops

    Genome medicine

All 93

Funding

33 grants since 2016

National Cancer Institute$24.7MNational Institute on Aging$3.5MNational Institute of General Medical Sciences$2.2M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Independent labs report that TP53 shortens mouse lifespan and inhibits the senescence-associated secretory phenotype in human cells. Mouse results also include no lifespan effect; a study reports extension in Eu-myc lymphoma and LFS models. Human cell experiments report that TP53 is required for ERCC1-deficiency-induced senescence; National Institutes of Health funding is named on 94 findings.

  2. Summary rewritten as its findings changed.

    As it read before

    Independent labs report TP53 shortening mouse lifespan; a mouse study reports extension in Eu-myc lymphoma and LFS models, and other mouse results include no effect. Independent labs also report TP53 suppressing the senescence-associated secretory phenotype in human cells. Authors have company affiliations in 7 of 256 findings; 6 of 193 papers declare company ties.

  3. Summary rewritten as its findings changed.

    As it read before

    TP53 shortens mouse lifespan and induces animal cellular senescence across independent labs, but Δ133p53α expression extends lifespan in progeria-model mice. One group reports human associations with blood clonal expansion and, at high variant allele fractions, hematological malignancy. An author is affiliated with Golden Biotech, and a paper declares company ties.

  4. Summary rewritten as its findings changed.

    As it read before

    A human study links TP53 to inferior chemotherapy outcomes in older adults with B-cell acute lymphoblastic leukemia; another links it to splenic CXCL10. One mouse-cell study shows nicotinamide mononucleotide decreases TP53; one human-cell study shows fisetin increases it.

  5. Summary written from the findings.

Latest

Dec 2025: 28Jan 2026: 63Feb 2026: 46Mar 2026: 44Apr 2026: 37May 2026: 48Jun 2026: 52Jul 2026: 41Aug 2026: 41Sep 2026: 40Oct 2026: 61Nov 2026: 37538 papers in 12 months
Antioxidants & Redox Signaling

Hydrogen sulfide may ease signs of heart aging in mice

In mice exposed to D-galactose, a hydrogen sulfide-releasing compound reduced signs of heart aging and activation of a protein involved in inflammation.In mice exposed to D-galactose, a hydrogen sulfide-releasing compound reduced signs of heart aging and activation of a protein involved in inflammation.

Mouse studyInterventions
Phytomedicine

Compound reduced kidney injury in mice with diabetes

Experiments in mice with diabetes-induced kidney disease found less kidney tubule cell senescence, a state in which cells stop dividing, after receiving procyanidin C1.Experiments in mice with diabetes-induced kidney disease found less kidney tubule cell senescence, a state in which cells stop dividing, after receiving procyanidin C1.

Mouse studyKidney injury
bioRxiv

Stress-response protein supports healthy aging in mouse liver

In experiments in aged mice, removing the stress-response protein p53 from liver cells increased inflammation, while activating it with a drug delayed the onset of…In experiments in aged mice, removing the stress-response protein p53 from liver cells increased inflammation, while activating it with a drug delayed the onset of frailty.

Preprint: mouse studyDNA damage response
bioRxiv

Protein levels alter drug sensitivity in lab-grown human cells

Cells still stopped dividing after radiation, but protein levels changed their secreted signals and sensitivity to a drug that kills senescent cells.Cells still stopped dividing after radiation, but protein levels changed their secreted signals and sensitivity to a drug that kills senescent cells.

Preprint: human cell studyMechanisms
bioRxiv

Tumors mix younger- and older-like molecular aging patterns

An analysis of breast cancer and five other cancers found mixed aging patterns, partly resembling those in normal tissue of the same origin.An analysis of breast cancer and five other cancers found mixed aging patterns, partly resembling those in normal tissue of the same origin.

Preprint: computational studyBiomarkers
Journal of Nanobiotechnology

Young-donor cell packages better eased osteoarthritis in mice

An experiment in male mice with surgically induced disease compared packages released by human joint-lining stem cells from young and aged donors.An experiment in male mice with surgically induced disease compared packages released by human joint-lining stem cells from young and aged donors.

Mouse studyOsteoarthritis

See all 2,514 papers on TP53